GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regeneron Pharmaceuticals Inc (WBO:REGN) » Definitions » Inventories, Other

Regeneron Pharmaceuticals (WBO:REGN) Inventories, Other : €563 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Regeneron Pharmaceuticals Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Regeneron Pharmaceuticals's other inventories for the quarter that ended in Mar. 2024 was €563 Mil.

Regeneron Pharmaceuticals's quarterly other inventories declined from Sep. 2023 (€503 Mil) to Dec. 2023 (€479 Mil) but then increased from Dec. 2023 (€479 Mil) to Mar. 2024 (€563 Mil).

Regeneron Pharmaceuticals's annual other inventories increased from Dec. 2021 (€397 Mil) to Dec. 2022 (€493 Mil) but then declined from Dec. 2022 (€493 Mil) to Dec. 2023 (€479 Mil).

Regeneron Pharmaceuticals Inventories, Other Historical Data

The historical data trend for Regeneron Pharmaceuticals's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Regeneron Pharmaceuticals Inventories, Other Chart

Regeneron Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only 360.81 354.20 396.92 492.58 478.77

Regeneron Pharmaceuticals Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 518.46 461.04 502.80 478.77 562.58

Regeneron Pharmaceuticals Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

Regeneron Pharmaceuticals (WBO:REGN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regeneron Pharmaceuticals Inc (WBO:REGN) » Definitions » Inventories, Other
Comparable Companies
VRTX MRNA BNTX ALNY BGNE BMRN RPRX SRPT INCY UTHR OCSE:NOVO B ASX:CSL XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX OCSE:GMAB SHSE:603392 SZSE:300122 XKRX:028300
Traded in Other Exchanges
REGN:USA REGN:Mexico RGO:Germany REGN34:Brazil
Address
777 Old Saw Mill River Road, Tarrytown, NY, USA, 10591-6707
Website
https://www.regeneron.com
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in immunology; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and CRISPR-based gene editing (Intellia).